On ECHEMI
Home > Drugs > Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
  • Founded in:

    1993-08-11
  • Country:

    China China
  • Address:

    No. 978 Chuansha Road, Pudong New Area, Shanghai
  • Tax NO.:

    91310115133738906M
  • Registered Funds:

    1,052,429,132 yuan
  • Website:

  • Email:

Related Drugs
Cefoperazone Sodium and Sulbactam Sodium for Injection
This product is a compound preparation, its components are 0.5g each of cefoperazone sodium and sulbactam sodium.
Name Description Content CAS NO. Registered Holders
Cefoperazone sodium

It has good antibacterial effect on Escherichia coli, Klebsiella, Proteus, Salmonella typhi, Shigella, Citrobacter and other Enterobacteriaceae and Pseudomonas aeruginosa. Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis are highly sensitive to it. It also has good effect on various groups of streptococci and pneumococci, and only has moderate effect on Staphylococcus aureus (methicillin-sensitive strains). It has good effect on most Gram-positive anaerobes and some Gram-negative anaerobes. It mainly inhibits the synthesis of bacterial cell walls.

More

It has good antibacterial effect on Escherichia coli, Klebsiella, Proteus, Salmonella typhi, Shigella, Citrobacter and other Enterobacteriaceae and Pseudomonas aeruginosa. Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis are highly sensitive to it. It also has good effect on various groups of streptococci and pneumococci, and only has moderate effect on Staphylococcus aureus (methicillin-sensitive strains). It has good effect on most Gram-positive anaerobes and some Gram-negative anaerobes. It mainly inhibits the synthesis of bacterial cell walls.

0.5g 62893-20-3 23
Sulbactam sodium

It has a weak antibacterial effect itself and is a competitive, irreversible beta-lactamase inhibitor. When used in combination with cefoperazone, it can increase the ability of cefoperazone to resist degradation by various beta-lactamases and produce a significant synergistic effect on cefoperazone.

More

It has a weak antibacterial effect itself and is a competitive, irreversible beta-lactamase inhibitor. When used in combination with cefoperazone, it can increase the ability of cefoperazone to resist degradation by various beta-lactamases and produce a significant synergistic effect on cefoperazone.

0.5g 69388-84-7 30
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.